Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
48000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of Series 10 Stock Acquisition Rights (with an exercise price adjustment clause) issued through a third-party allotment
発行・処分する株式数
48,000 shares (number of shares issued in October 2026)
Existing Shares and Increase
+0.80%Rate of increase
6,150,357 shares6,198,357Shares
0.80% (exercise ratio relating to exercise restrictions; 48,000 shares issued across all series / 5,987,357 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥313 (exercise price on 19 and 22 October 2026). Details of the exercise price adjustment clause and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
14,000 rights issued in total (480 exercised; 11,890 unexercised at month-end. 3.43% of the total number issued was exercised during the target month)
Payment date
23 July 2026 (date of issue of the Stock Acquisition Rights)
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions.
Most recent equity financing
23 July 2026: Issuance of Series 10 Stock Acquisition Rights (with an exercise price adjustment clause) through a third-party allotment (total amount: Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of Series 10 Stock Acquisition Rights (with an exercise price adjustment clause) issued through a third-party allotment |
| Number of shares to be issued or disposed of | 48,000 shares (number of shares issued in October 2026) |
| Payment date | 23 July 2026 (date of issue of the Stock Acquisition Rights) |
| Dilution Rate | 0.80% (exercise ratio relating to exercise restrictions; 48,000 shares issued across all series / 5,987,357 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 6,150,357 shares (as of the end of the month preceding the target month) → 6,198,357 shares (calculated figure reflecting the shares issued in October 2026) |
| Exercise price | ¥313 (exercise price on 19 and 22 October 2026). Details of the exercise price adjustment clause and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | 14,000 rights issued in total (480 exercised; 11,890 unexercised at month-end. 3.43% of the total number issued was exercised during the target month) |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions. |
| Most recent equity financing | 23 July 2026: Issuance of Series 10 Stock Acquisition Rights (with an exercise price adjustment clause) through a third-party allotment (total amount: Not disclosed) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status for October 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.